Description

CJC-1295 with DAC – 5mg

CJC-1295 with DAC (Drug Affinity Complex) is a long-acting synthetic peptide designed to support sustained growth hormone (GH) release by extending the half-life of CJC-1295 in the body. Unlike short-acting GHRH analogs, the DAC modification allows for prolonged activity, reducing the need for frequent dosing in research protocols.
This peptide works by binding to the growth hormone–releasing hormone (GHRH) receptor, helping maintain elevated and stable GH levels over an extended period. Due to its long duration of action, CJC-1295 with DAC is commonly studied for its role in growth hormone signaling, metabolic regulation, recovery processes, and age-related GH decline.
Each vial contains 5mg of lyophilized powder and is intended strictly for laboratory research purposes.

Key Features
Long-acting GHRH analog with DAC technology
Supports sustained growth hormone release
Extended half-life compared to non-DAC versions
Lyophilized powder for stability and storage
5mg per vial

Product Specifications
Compound: CJC-1295 with DAC
Quantity: 5mg
Form: Lyophilized powder
Purity: High purity (research grade)
Storage: Refrigerate

Research Use Disclaimer
This product is not for human consumption. Sold for research and laboratory use only. Not intended to diagnose, treat, cure, or prevent any disease.